Bruker (BRKR) reported Q3 non-GAAP net income Wednesday of $0.56 per diluted share, up from $0.45 a year earlier.
Analysts polled by FactSet expected $0.42.
Revenue for the quarter ended Sept. 30 was $874.0 million, up from $860.5 million a year earlier.
Analysts expected $865.2 million.
For 2026, the company continues to expect non-GAAP EPS of $2.10 to $2.15 and lowered the projected revenue range to between $3.52 billion and $3.56 billion, down from its previous $3.54 billion to $3.57 billion. Analysts expect $2.12 and $3.56 billion, respectively.
Shares of the company were up 8% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments